Free Trial
ASX:SMR

Stanmore Resources (SMR) Stock Price, News & Analysis

Stanmore Resources logo

About Stanmore Resources Stock (ASX:SMR)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
3.20 million shs
Average Volume
N/A
Market Capitalization
A$1.48 billion
P/E Ratio
5.40
Dividend Yield
7.45%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive SMR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Stanmore Resources and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SMR Stock News Headlines

7 market signals flashing red right now
Right now, the same 7 key indicators that predicted 1929, the 1970s stagflation, and the 2008 meltdown are all flashing red at the same time.tc pixel
See More Headlines

SMR Stock Analysis - Frequently Asked Questions

Stanmore Resources Limited (ASX:SMR) released its quarterly earnings results on Tuesday, February, 12th. The company reported $0.08 earnings per share for the quarter. Stanmore Resources had a trailing twelve-month return on equity of 15.63% and a net margin of 10.57%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Stanmore Resources investors own include Aldeyra Therapeutics (ALDX), Biodexa Pharmaceuticals (BDRX), Candel Therapeutics (CADL), Cleanspark (CLSK), CXApp (CXAI), DiaMedica Therapeutics (DMAC) and Dyne Therapeutics (DYN).

Company Calendar

Last Earnings
2/12/2019
Today
10/15/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Industry
Coking Coal
Sub-Industry
Fabricated Products
Current Symbol
ASX:SMR
CIK
N/A
Fax
N/A
Employees
440
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
A$0.44
Trailing P/E Ratio
5.40
Forward P/E Ratio
N/A
P/E Growth
0.03
Net Income
A$268.40 million
Net Margins
10.57%
Pretax Margin
N/A
Return on Equity
15.63%
Return on Assets
7.75%

Debt

Debt-to-Equity Ratio
44.24
Current Ratio
1.01
Quick Ratio
1.27

Sales & Book Value

Annual Sales
A$2.54 billion
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
3.69
Book Value
A$1.95 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
901,390,000
Free Float
N/A
Market Cap
A$1.48 billion
Optionable
Not Optionable
Beta
0.21
10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (ASX:SMR) was last updated on 10/15/2025 by MarketBeat.com Staff
From Our Partners